EUVIMEDEUVIMED entdecken
Leserbrief

Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapy

Isabelle Desmoulins, Hélène Bellio, Nathalie Méjean, Caroline Truntzer, Sylvain Ladoire

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.03.030 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Isabelle Desmoulins und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Georges-François Leclerc Centre, 1 rue du Professeur Marion, 21000 Dijon, France. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunoconjugates, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsImmunoconjugatesBrain NeoplasmsHumansFemaleTrastuzumabQuinazolinesErb-b2 Receptor Tyrosine KinasesAntineoplastic Combined Chemotherapy ProtocolsOxazolesPyridines

Substanzen

TrastuzumabQuinazolinesImmunoconjugatesErb-b2 Receptor Tyrosine KinasestucatinibOxazolesPyridines

Autor:innen und Institutionen

  • Department of Medical Oncology, Georges-François Leclerc Centre, 1 rue du Professeur Marion, 21000 Dijon, France.
  • Department of Radiology, Georges-François Leclerc Centre, 1 rue du Professeur Marion, 21000 Dijon, France.
  • Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Bioinformatic Core Facility, Georges-François Leclerc Cancer Center, Dijon, France; Genomic and Immunotherapy Medical I…
  • Department of Medical Oncology, Georges-François Leclerc Centre, 1 rue du Professeur Marion, 21000 Dijon, France; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Unive…

Zitieren

APA

Desmoulins, I., Bellio, H., Méjean, N., Truntzer, C., & Ladoire, S. (2023). Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapy. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.03.030

Vancouver

Desmoulins I, Bellio H, Méjean N, Truntzer C, Ladoire S. Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapy. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.03.030

BibTeX
@article{Desmoulins2023,
  author = {Desmoulins, Isabelle and Bellio, Hélène and Méjean, Nathalie and Truntzer, Caroline and Ladoire, Sylvain},
  title = {Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapy},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.03.030}
}
Kostenlos starten →